Maso Capital Partners LTD Zymeworks Inc. Transaction History

Maso Capital Partners LTD

  • $84.2 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$6.0 - $16.98 $568,320 - $1.61 Million
-94,720 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$27.35 - $37.28 $2.59 Million - $3.53 Million
94,720 New
94,720 $2.75 Million

Others Institutions Holding ZYME

# of Institutions
1
Shares Held
296K
Call Options Held
0
Put Options Held
0
View Full List

About Zymeworks Inc.

ZYME Quotes by TradingView
  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $895M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Maso Capital Partners LTD Portfolio

Follow Maso Capital Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maso Capital Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maso Capital Partners LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email